Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency Projects
-
ContextLogic Encourages Stockholders to Vote at the Upcoming Special Meeting
-
Eurofins Genomics AgriGenomics Europe and Gencove announce collaboration to offer complete solution for low-pass whole genome sequencing
-
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
-
Ormat Technologies, Inc. to Host Conference Call Announcing First Quarter 2024 Financial Results
-
Heidelberg Materials North America Announces New Texas Lehigh Cement Company Slag Facility in Houston
-
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Canc
-
Sysco to Announce Third Quarter Fiscal Year 2024 Financial Results on April 30
-
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
-
Enphase Energy Announces Conference Call to Review First Quarter 2024 Financial Results Tuesday, April 23, 2024 at 4:30 p.m. Eastern Time
-
Golden Matrix Announces Completion of Acquisition of the MeridianBet Group
-
Start of Clinical Research with Hiroshima University on Photon-Counting CT
-
eFFECTOR Therapeutics to Participate in Upcoming Investor Conference
-
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
-
Rockridge Receives Exploration and Drilling Permit for its Flagship Knife Lake Copper Project in Saskatchewan
-
Westwood Launches First Exchange-Traded Fund: Westwood Salient Enhanced Midstream Income ETF (MDST)
-
NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiov
-
LVT Unveils Immix Integration and New Cameras to Bolster Intelligent Physical Security Ecosystem
-
UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US
-
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cance
-
Certiverse Attains SOC 2 Compliance, Elevating Standards in Certification and Licensure Industry
-
Inspired Entertainment, Inc. Receives Expected Nasdaq Notification Regarding Delayed Form 10-K
-
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing
-
DOD AWARDS $272.6 MILLION ENGINEERING SERVICES CONTRACT TO DCCA
-
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
-
STACK Infrastructure Secures $3.3 Billion in Green Financing
-
A Visionary Alliance: Star Robotics and Guident Redefine Possibilities with Strategic Partnership
-
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
-
Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caus
-
Intermex Announces New Headquarters at the Datran Center, Miami-Dade
-
Lassila & Tikanoja plc will publish Interim Report January-March on 26 April 2024
-
Star Bulk Completes Merger With Eagle Bulk
-
Invesco Ltd: Form 8.3 - DS Smith PLC Public dealing disclosure
-
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
-
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
-
BNP Paribas Primary New Issues: No STAB Notice - NEOPHARMED GENTILI
-
Carbon Revolution Announces Record Revenue Results for First Half 2024
-
Elis : Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 03 2024
-
BNP Paribas Primary New Issues: No STAB Notice - EUTELSAT
-
PTX Metals Announces Update on W2 Copper-Nickel-PGE Project and Drill Program in Northwestern Ontario
-
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
-
Midland Expands Its Land Position for Gold in James Bay With the New Caniapisc Au Project
-
Vanqua Bio Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating VQ-101, its Small Molecule GCase Activator for GBA-Parkinson’s Disease and Related Disorders
-
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
-
SL Green Signs Leases Totaling 104,000 Square Feet at One Madison Avenue
-
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
-
MariMed Closes Acquisition of Second Maryland Dispensary
-
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
-
Dragonfly Energy to Report Fourth Quarter and Year End 2023 Financial and Operational Results on April 15, 2024
-
Chef Jason Triail of The Habit Burger Grill Given His Biggest Challenge Yet... By a Seven-Year-Old!

